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In the face of threat: neural and endocrine correlates of
impaired facial emotion recognition in cocaine dependence
KD Ersche1,2, CC Hagan1, DG Smith2,3, PS Jones1, AJ Calder4,✠ and GB Williams2,5
The ability to recognize facial expressions of emotion in others is a cornerstone of human interaction. Selective impairments in
the recognition of facial expressions of fear have frequently been reported in chronic cocaine users, but the nature of these
impairments remains poorly understood. We used the multivariate method of partial least squares and structural magnetic
resonance imaging to identify gray matter brain networks that underlie facial affect processing in both cocaine-dependent (n= 29)
and healthy male volunteers (n= 29). We hypothesized that disruptions in neuroendocrine function in cocaine-dependent
individuals would explain their impairments in fear recognition by modulating the relationship with the underlying gray matter
networks. We found that cocaine-dependent individuals not only exhibited significant impairments in the recognition of fear, but
also for facial expressions of anger. Although recognition accuracy of threatening expressions co-varied in all participants with
distinctive gray matter networks implicated in fear and anger processing, in cocaine users it was less well predicted by these
networks than in controls. The weaker brain-behavior relationships for threat processing were also mediated by distinctly different
factors. Fear recognition impairments were influenced by variations in intelligence levels, whereas anger recognition impairments
were associated with comorbid opiate dependence and related reduction in testosterone levels. We also observed an inverse
relationship between testosterone levels and the duration of crack and opiate use. Our data provide novel insight into the
neurobiological basis of abnormal threat processing in cocaine dependence, which may shed light on new opportunities facilitating
the psychosocial integration of these patients.
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INTRODUCTION
Facial expressions of emotion are important social signals of
information, reflecting the emotional state of others and helping
us to predict their behavior and adjust our responses accordingly.1
Chronic abuse of stimulant drugs like cocaine and amphetamines
has repeatedly been shown to selectively impair the recognition
of fear in others2–4—an important social cue that signals
immediate threat5—and this failure can lead to maladaptive
behavior and social difficulties.6 Yet the relationship between
stimulant drug dependence, impairments in fear recognition and
social behavior remains elusive. It is conceivable that these
impairments may predate stimulant dependence as adolescents
with conduct disorder—who have an increased risk for develop-
ing drug addiction in adulthood7—exhibit impairments in
recognizing negative facial affect, including fear.8,9 An alternative,
but not mutually exclusive, possibility is that prolonged drug
abuse impairs emotion processing abilities. However, prior studies
failed to find a direct relationship between the duration of
stimulant use and fear recognition impairments,2,4,10 suggesting
that these relationships are more likely to be indirect.
Imbalance in the levels of steroidal hormones, such as cortisol
and testosterone, may have a mediating role. Cortisol and
testosterone are the end products of the hypothalamus–
pituitary–adrenal (HPA) axis and the hypothalamus–pituitary–
gonadal (HPG) axis, respectively, and together they regulate an
individual’s response to threat.11 Cortisol directly influences
autonomic neural systems associated with the processing of
threatening information, such as those conveyed by fearful or
angry facial expressions,12–14 while testosterone is thought to
modulate the behavioral response to threat.15,16 Both hormones
have mutually antagonistic actions—that is, cortisol attenuates
the production of testosterone by suppressing HPG-activity, and
testosterone reduces cortisol by inhibiting HPA-activity at the level
of the hypothalamus.17 An imbalance between the HPA and HPG
axes, as measured by peripheral levels of cortisol and testosterone,
has been shown to mediate facial affect processing through their
endocrine actions on neural activity in the amygdala and
orbitofrontal cortex.18–23 These areas, along with the inferior
occipital and fusiform gyri and the prefrontal cortex, make up the
distributed network of cortical and subcortical brain structures
that process facial affect.24 Thus, as both hormones can affect
brain structure25,26 and functional connectivity during facial
emotion recognition,27,28 it is conceivable that hormonal changes
mediate threat processing through changes in these underlying
structural brain networks. Indeed, decreased functional connec-
tivity or damage to structures within this network have repeatedly
been linked with impairments in emotion perception, including
fear recognition.29–31
Preclinical evidence suggests that repeated use of cocaine
enhances HPA axis activity and suppresses the HPG axis,32 as
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reflected by increased cortisol and decreased testosterone
levels.33–35 However, studies of hormonal changes in human
long-term cocaine users have been inconsistent.36,37 Using data-
driven multivariate analysis methods, we sought to first determine
the neural correlates associated with facial threat recognition, and
subsequently investigate the influence of steroidal hormones on
this brain-behavior relationship. We hypothesized that imbalances
between HPA and HPG axes activity in cocaine-dependent
individuals (CDIs) would explain impairments in recognizing fear
via associated neuroanatomical networks.
MATERIALS AND METHODS
Study sample
Sixty-five male volunteers, aged between 20 and 60 years, were recruited
from the local community. Thirty-five individuals had a history of chronic
cocaine abuse, satisfying the DSM-IV-TR38 criteria for cocaine dependence,
whereas the remaining 30 individuals were healthy and without a personal
and family history of drug abuse. Exclusion criteria for all volunteers
included a lifetime history of a psychotic disorder, neurological illness or
traumatic head injury, an autoimmune or metabolic disorder, or HIV-
infection. All volunteers consented in writing before being screened for
current psychiatric disorders using the Mini-International Neuropsychiatric
Inventory.39 Psychopathology in drug users was further evaluated using
the Structured Clinical Interview for DSM-IV.40 All participants completed
the National Adult Reading Test41 to provide an estimate of verbal IQ, the
State–Trait Anxiety Inventory42 to record temporary and stable feelings of
anxiety, and the Beck Depression Inventory (BDI-II)43 to measure
depressive mood. Before behavioral tasks, a blood sample was drawn in
all participants to measure serum levels of cortisol and testosterone. Urine
samples were tested for undeclared drugs; all samples provided by the
healthy volunteers were negative and all except four urine samples
provided by CDIs tested positive for stimulants. The protocol was approved
by the National Research Ethics Committee (NREC10/H0306/69, PI: KD
Ersche); data from both groups have been published previously.44,45
All CDIs were non-treatment seeking and had been actively using
cocaine/crack-cocaine for an average of 17 years (±8.0 s.d.). Half of the CDIs
smoked (n=12) or injected (n= 9) crack-cocaine, while the other half used
powdered cocaine intranasally (n=14). Besides meeting the DSM-IV-TR
criteria for cocaine dependence, several CDIs also met criteria for
dependence on another substance (91% nicotine, 43% opiates, 29%
alcohol, 20% cannabis, 3% amphetamines) and used other drugs
sporadically (68% cannabis, 20% sedatives, 15% opiates, 14% ecstasy, 3%
hallucinogens). Eleven CDIs were prescribed methadone (mean dose: 55
mg± 16.2 s.d.), three were prescribed buprenorphine (mean dose: 3
mg± 2.6 s.d.) and four received narcotic-like pain relief medication on
prescription. Three CDIs were prescribed antidepressants, three were
prescribed benzodiazepines and one received d-amphetamines on
prescription. None of the healthy volunteers satisfied criteria for alcohol
abuse or dependence, nor were they taking prescribed or illicit drugs on a
regular basis. Seventy percent of healthy volunteers were either past or
current smokers of tobacco, and 57% reported having social experiences
with cannabis.
Behavioral, brain and endocrine data collection
All participants first completed the Benton Facial Recognition Test,46 a
face-matching task used to verify the ability to perceptually discriminate
faces. Participants were presented with six black-and-white photographs of
unfamiliar faces and asked to identify first one and subsequently three
photographs that matched the target face simultaneously shown. A
performance score was calculated from the number of correct responses,
taking into account participants’ age and education. Next, participants
were tested on facial expression recognition using the computerized
Emotion Hexagon task.47 It consisted of morphed black-and-white images
spanning six facial expression pairs: happiness–surprise, surprise–fear,
fear–sadness, sadness–disgust, disgust–anger, anger–happiness. The ratio
of blending within each expression pair varied in 20% increments (that is,
90% happy blended with 10% surprise, 70% happy and 30% surprise, 50%
happy and 50% surprise, 30% happy and 70% surprise and 10% happy
blended with 90% surprise). Faces were shown for a maximum of 5 s, and
participants were asked to judge by button-press which of the six
emotions each face was expressing. Participants had no time limit for their
judgments and received no feedback about the accuracy of their
responses. Task performance was reflected by the percentage of correct
responses for each emotion.
After completion of the behavioral tasks (between 1200 and 1300 hours
GMT), blood samples were drawn from each participant and sent to the
Department of Pathology at Addenbrooke’s Hospital (www.cuh.org.uk),
where serum levels of cortisol and testosterone were determined using
competitive chemiluminescent immunoassays on the Siemens ADVIA
Centaur Immunoassay System. Participants then underwent a whole-brain
T1-weighted magnetic resonance (MR) scan at the Wolfson Brain Imaging
Centre, University of Cambridge, UK. The MR images were acquired using a
Siemens TIM-Trio 3T system with a magnetization-prepared rapid acquisi-
tion gradient-echo sequence (176 slices of 1mm thickness, TR =2300ms,
TE= 2.98ms, TI = 900ms, flip angle= 9°, FOV= 240× 256). Out of the final
sample of 58 participants, three MR imaging scans (two controls, one CDI)
were of poor quality and therefore not included in the analysis.
Statistical analyses
Three participants’ behavioral data were lost due to technical failure (one
control, two CDIs). CDIs without a stimulant-positive urine screen (n=4)
were also excluded to avoid potentially confounding effects of drug
abstinence, leaving a final sample of 58 participants (29 individuals per
group). Data were analyzed using the Statistical Package for the Social
Sciences (SPSS, version 22; IBM, Armonk, NY, USA). Group differences
regarding demographic, behavioral and endocrine measures were
analyzed using independent samples t-tests. Performance on the Hexagon
task was analyzed using multivariate analysis of variance to take into
account the relationships between the six emotions. We initially included
verbal IQ, depressive mood and trait-anxiety as covariates in the analysis to
statistically control for group differences in these variables, but all variables
interacted with group status, suggesting that they are defining features of
these groups. Consequently, co-varying for them would not be
appropriate.48 To determine potentially confounding effects of the
aforementioned demographic variables and the influence that comorbidity
had on the results, we performed a two-step hierarchical regression model.
In step 1, we included dependence status as three separate dichotomous
variables (D1: not cocaine-dependent, cocaine-dependent; D2: not opiate-
dependent, opiate-dependent; D3: not alcohol-dependent, alcohol-depen-
dent) and then added the continuous variables verbal IQ, depressive mood
and trait-anxiety to the model in step 2. Significant results of the regression
model were tested for mediator effects using the process software tool
(version 2.13) by Andrew F. Hayes (www.afhayes.com), which was
implemented in SPSS. We also calculated Pearson’s correlation coefficients
to evaluate putative relationships between outcome variables and drug-
taking measures. All statistical tests were two-tailed and significance levels
were set at 0.05.
Gray matter density maps were analyzed using FSL-VBM (www.fmrib.ox.
ac.uk/fsl/fslvbm, v.4.1). Non-brain tissues were removed using the brain
extraction tool of FSL and tissue-type segmentation was performed using
FAST. The resulting gray matter partial-volume images were aligned to
MNI-152 standard space using the affine registration tool FLIRT, followed
by nonlinear registration using FNIRT, which uses a b-spline representation
of the registration warp field. A study-specific gray matter template was
made to which the native gray matter images were nonlinearly re-
registered. To correct for local expansion or contraction, the registered
partial-volume images were modulated by division with the Jacobian warp
field. The modulated segmented images were then smoothed with an
isotropic Gaussian kernel with full width half maximum=2.3 mm. Group
comparisons of the gray matter maps were performed using CamBA
software for permutation testing,49 v.2.3.0 (http://www.bmu.psychiatry.
cam.ac.uk/software/) and thresholded at cluster-level statistics of η= 1
error clusters per image.
The influence of steroidal hormones in predicting facial affect
processing from brain structure
We used partial least squares methods50 to determine covariance between
brain regions (voxels) across the entire brain and successful task
performance (recognition accuracy). For the calculation of the correlation
maps, we only included brain regions where the mean gray matter density
over all participants was 40.01. We determined the overall strength of
each correlation map by calculating the root-mean-squared correlation
coefficient over the entire brain.51 The significance of the correlation
pattern was then tested using permutation methods—that is, the input
images were randomly re-labeled and the root-mean-squared correlation
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was re-calculated to generate a null distribution for the hypothesis (1,000
permutations were used).
In partial least squares method, each voxel in the correlation map is
given a numerical weight (salience) reflecting how strongly that voxel is
related to the behavioral variable of interest. Salience can be either
positive or negative depending on whether the voxel shows a positive or
negative relationship with the pattern identified. Partial least squares
method also computes a brain score that reflects the strength of each
participant’s brain-behavior relationship. As CDIs exhibited recognition
impairments for both fearful and angry facial expressions, we investigated
both expressions separately. Brain scores were imported into SPSS for
statistical group comparisons,51 and multiple stepwise regression was used
to determine the influence of testosterone and cortisol levels on the brain
scores for fear and anger recognition. We then conducted bootstrap-
mediation analysis restricted to the significant results of the regression
analysis using the process software tool (version 2.13; www.afhayes.com)
implemented in SPSS.
RESULTS
Demographic and clinical data
Descriptive data is shown in Table 1. The two groups were well
matched for age but differed significantly with regard to verbal IQ,
anxiety and dysphoric mood. Serum levels of testosterone were
significantly reduced in CDIs, while cortisol levels were not
measurably different between the groups. CDIs and healthy
control volunteers did not differ on vital signs, including pulse rate
(t56 = 1.12, P= 0.247), systolic (t56 = 0.12, P= 0.908) and diastolic
blood pressure (t56 = 0.98, P= 0.333), indicating that the CDIs were
not acutely intoxicated.
No differences were observed between subgroups of CDIs with
comorbid opiate or alcohol dependence regarding demographics,
intelligence, anxiety, mood, physiological measures and duration
or compulsive pattern of stimulant use (all P40.1). However,
significantly lower levels of testosterone were found in CDIs with
comorbid opiate dependence compared with their non-opiate-
dependent counterparts (t27 =− 2.36, P= 0.026), suggesting that
the low levels of testosterone observed in the cocaine group may
have been driven, at least in part, by the low testosterone levels in
CDIs with comorbid opiate dependence.
Behavioral data: facial identification and affect processing
Compared with their healthy peers, CDIs performed equally well in
matching the unfamiliar faces (t54 = 0.10, P= 0.324), confirming no
significant group differences in facial discrimination ability.
However, one participant in each group (o4% of the entire
sample) scored outside the normal range; this is in keeping with
predictions that ~ 8% of normal individuals without a known
pathology underperform on this test.52 To ensure that our findings
were not confounded by deficits in facial perception, all analyses
were repeated after removal of these two individuals.
As shown in Figure 1, CDIs exhibited deficits on the Emotion
Hexagon task in recognizing not only fearful (F1,56 = 12.34,
P= 0.001) but also angry (F1,56 = 6.03, P= 0.017) facial expressions.
On closer inspection, we noticed that CDIs misclassified expres-
sions of fear significantly more often than control volunteers as
expressions of either sadness (Fisher’s exact P= 0.032) or surprise
(Fisher’s exact P= 0.070). No systematic misclassifications were
observed for angry faces. The two groups did not differ with
respect to time needed for classifications (Table 1).
Hierarchical regression revealed that drug dependency
(R2 = 0.25, F3,51 = 5.72, P= 0.002) accounted for a quarter of the
variance of fear recognition (ΔR2 = 0.25, P= 0.002), and the
inclusion of demographic variables to the model (R2 = 0.38,
F6,48 = 4.92, P= 0.001) explained an additional 13% of the variance
(ΔR2 = 0.13, P= 0.027). As can be seen from Table 2, cocaine
dependence was significant at step 1 (β=− 0.37; P= 0.023), but
this effect did not survive when verbal IQ (β= 0.42; P= 0.005) was
Table 1. Demographics, clinical variables and facial affect recognition performance for healthy male volunteers and cocaine-dependent men
Descriptive variables Control group (N=29) Cocaine group (N=29) Group comparison
Mean s.d. Mean s.d. t or F P
Age (years) 36.8 ± 10.1 35.5 ± 8.7 0.53 0.599
Verbal IQ (NART score) 115.2 ± 5.9 104.1 ± 9.9 5.12 o0.001
Serum testosterone (nmol/L)a 15.4 ± 5.0 11.8 ± 5.1 2.70 0.009
Serum cortisol (nmol/L)a 282.3 ± 96.8 316.3 ± 146.0 − 1.03 0.306
Testosterone–cortisol ratio 0.07 ± 0.04 0.04 ± 0.03 2.40 0.020
Dysphoric mood (BDI-II score) 3.3 ± 4.1 19.8 ± 12.0 − 7.01 o0.001
State anxiety (STAI score) 28.8 ± 6.8 39.8 ± 14.4 − 3.69 0.001
Trait anxiety (STAI score) 32.0 ± 8.5 47.2 ± 12.7 − 5.29 o0.001
Facial identity recognition (performance score)
Benton test 23.1 ± 1.9 22.6 ± 2.0 1.00 0.324
Facial expression recognition accuracy (% correct responses)
Happy 97.8 ± 6.4 96.4 ± 7.5 0.57 0.455
Surprise 88.3 ± 13.3 87.9 ± 12.6 0.01 0.920
Fear 77.4 ± 15.5 60.9 ± 20.1 12.33 0.001
Sad 93.4 ± 12.3 89.1 ± 17.3 1.20 0.279
Disgust 72.9 ± 29.6 61.0 ± 32.8 2.10 0.152
Anger 80.0 ± 18.8 66.0 ± 24.2 6.03 0.017
Facial expression recognition latency (mean response time in seconds)
Happy 1.45 ± 0.30 1.54 ± 0.61 0.55 0.462
Surprise 1.80 ± 0.51 2.03 ± 0.67 2.13 0.150
Fear 2.16 ± 0.84 2.29 ± 0.52 0.48 0.491
Sad 1.72 ± 0.49 1.91 ± 0.77 1.25 0.268
Disgust 1.97 ± 1.08 2.21 ± 1.09 0.73 0.398
Anger 2.14 ± 0.63 2.32 ± 0.66 1.13 0.292
Abbreviations: BDI-II, Beck Depression Inventory; NART, National Adult Reading Test; STAI, State–Trait Anxiety Inventory. aReference ranges provided by the
laboratory: testosterone 8–29 nmo/L and cortisol 280–650 nmol/L.
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included in the model at step 2, suggesting that the significant
direct effect of cocaine dependence was mediated by verbal IQ.
Drug-dependency also had a significant effect on the recognition
of anger (R2 = 0.34, F3,51 = 10.37, Po0.001), explaining 38% of the
variance (ΔR2 = 0.38, Po0.001). When demographic variables
were added to the model (R2 = 0.43, F6,48 = 7.66, Po0.001), they
explained an additional 11% of the variance (ΔR2 = 0.11, P= 0.024).
As shown in Table 2, the significant effect of dependency was
largely driven by opiate dependence (β=− 0.60; Po0.001) and
this effect survived when verbal IQ (β=− 0.35; P= 0.009) was
included in the model, suggesting that opiate dependence had a
critical role in the observed impairments in anger recognition.
Indeed, when opiate-dependent patients were excluded from the
sample, the groups no longer differed in terms of anger
recognition (F1,44 = 0.03, P= 0.876) but remained significantly
different for fear recognition (F1,44 = 5.58, P= 0.023).
Brain data and prediction of individual variation in facial affect
processing
Univariate comparisons of whole-brain gray matter maps did not
reveal any significant differences between the groups. Permuta-
tion tests showed that networks of gray matter variation
significantly correlated in both groups with recognition of fear
(P= 0.035) and anger (Po0.001). The networks for fear and anger
recognition both encompassed distributed clusters across both
hemispheres in the cingulum, inferior orbitofrontal gyrus, middle
frontal gyrus, middle and superior temporal cortices, and fusiform
gyrus, as well as parietal regions and subcortical structures
including the amygdala and the hippocampus (Figure 2; for
anatomical details, see Supplementary Tables S1 and S2). No
significant overall laterality effects were identified for either the
cluster size or the significant salience within each region for either
fear or anger. The two networks did, however, differ notably in
terms of cluster size and salience, reflecting the degree of regional
brain-behavior correlation for each expression. For example,
deficits in gray matter volume in the amygdala correlated with
performance for both facial expressions, but the cluster size for
fear was smaller and with higher salience than for anger, whereas
the cluster for anger recognition comprised a larger volume but
had lower salience. Group comparisons of the brain scores, which
reflect the degree to which an individual’s gray matter distribution
explains their task performance, showed significantly lower brain
scores in CDIs for both fear (t53 = 2.88, P= 0.006) and anger
(t53 = 2.04, P= 0.046) compared with control volunteers (Figure 1).
Hierarchical regression for the brain score of fear revealed a
significant effect of drug dependency (R2 = 0.20, F3,50 = 5.52,
Figure 1. Group comparisons of facial affect recognition performance. As shown in the two graphs at the top, CDIs recognized significantly
fewer facial expressions depicting fear (a) and anger (b) compared with their non-drug-using healthy peers. To identify the neural correlates of
fear and anger recognition impairments in the cocaine group, we used PLS analysis to identify gray matter networks that co-vary with
participants’ recognition performance of fearful and angry faces, respectively. PLS determines covariance between brain voxels and
recognition accuracy across the entire brain and computes from the summary of all the voxels of the network for each participant a brain
score, which indicates how well the identified network reflects behavioral performance. The two graphs at the bottom show that CDIs’ brain
scores for both fear (c) and anger (d) were significantly lower compared with those of their healthy peers, indicating that CDIs ability to
recognize fearful and angry faces is less well explained by the identified gray matter networks. CDI, cocaine-dependent individual; PLS, partial
least squares method.
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P= 0.002), explaining a quarter of the variance (ΔR2 = 0.25,
P= 0.002). Inclusion of demographic variables to the model
(R2 = 0.29, F6,47 = 4.63, P= 0.001) accounted for a further 12% of
the variance (ΔR2 = 0.12, P = 0.037). Although cocaine dependence
significantly predicted the brain score of fear (β=− 0.35, P= 0.031),
this effect did not survive when verbal IQ (β= 0.35,P= 0.018) was
added to the model in step 2 (see Table 2), suggesting a
mediating effect of IQ. We subsequently confirmed this in a
mediation analysis showing that the significant direct effect of
cocaine dependence on the fear brain score (t=− 2.89, P= 0.006)
became nonsignificant (t=− 1.03, P= 0.306) when IQ (t= 2.48,
P= 0.016) was included in the model (see Figure 3a).
With regard to the brain score of anger, there was also a
significant effect of dependence (R2 = 0.31, F3,50 = 7.30, Po0.001),
which accounted for 30% of the variance (ΔR2 = 0.31, Po0.001).
As shown in Table 2, opiate dependence significantly predicted
the brain score of anger (β=− 0.516, P= 0.001), and the inclusion
of demographic variables (R2 = 0.37, F6,47 = 4.60, P= 0.001) did not
explain any further variance (ΔR2 = 0.07, P= 0.196).
Table 2. Summary of hierarchical regression analyses for variables predicting successful recognition of facial emotions and underneath the
brain-behavior relationships (as reflected by the brain scores)
Predicting variables Fear recognition Predicting variables Fear recognition
B SEB β B SEB β
Step 1 Step 2
Cocaine dependence − 14.61 6.25 − 0.37* Cocaine dependence − 7.77 7.48 − 0.20
Opiate dependence − 11.68 6.87 − 0.24 Opiate dependence − 10.81 6.47 − 0.22
Alcohol dependence 9.06 7.28 0.17 Alcohol dependence 10.45 6.94 0.19
ΔR2 0.25** Verbal IQ (NART) 0.85 0.29 0.42**
Depressive mood (BDI-II) − 0.18 0.36 − 0.11
Anxiety (STAI-T) 0.33 0.30 0.22
ΔR2 0.13*
Predicting variables Brain score fear Predicting variables Brain score fear
B SEB β B SEB β
Step 1 Step 2
Cocaine dependence − 6.12 2.77 − 0.35* Cocaine dependence − 2.76 3.33 − 0.16
Opiate dependence − 5.25 3.02 − 0.25 Opiate dependence − 4.7 2.87 − 0.22
Alcohol dependence 5.9 3.2 0.25 Alcohol dependence 6.87 3.07 0.29*
ΔR2 0.25** Verbal IQ (NART) 0.31 0.13 0.35*
Depressive mood (BDI-II) − 0.21 0.16 − 0.30
Anxiety (STAI-T) 0.21 0.13 0.32
ΔR2 0.13*
Predicting variables Anger recognition Predicting variables Anger recognition
B SEB β B SEB β
Step 1 Step 2
Cocaine dependence − 1.22 6.47 − 0.03 Cocaine dependence 12.58 7.71 0.28
Opiate dependence − 32.94 7.1 − 0.60** Opiate dependence − 31.62 6.67 − 0.58**
Alcohol dependence 1.46 7.53 0.02 Alcohol dependence 1.93 7.16 0.03
ΔR2 0.38** Verbal IQ (NART) 0.81 0.3 0.35**
Depressive mood (BDI-II) − 0.28 0.37 − 0.15
Anxiety (STAI-T) − 0.04 0.31 − 0.02
ΔR2 0.11*
Predicting variables Brain score anger Predicting variables Brain score anger
B SEB β B SEB β
Step 1 Step 2
Cocaine dependence − 1.32 2.99 − 0.07 Cocaine dependence 3.02 3.74 0.15
Opiate dependence − 12.13 3.27 − 0.52** Opiate dependence − 11.53 3.22 − 0.49
Alcohol dependence 4.53 3.46 0.17 Alcohol dependence 5.24 3.46 0.20
ΔR2 0.30** Verbal IQ (NART) 0.21 0.14 0.21*
Depressive mood (BDI-II) − 0.24 0.18 −0.30
Anxiety (STAI-T) 0.11 0.15 0.15
ΔR2 0.07
Abbreviations: B, β-coefficient; β: standardized β-coefficient for the regression model; BDI-II, Beck Depression Inventory; NART, National Adult Reading Test;
R2, coefficient of determination; SEB, standard error of the β-coefficient; STAI-T, State-Trait Anxiety Inventory (trait subscale); Δ, change. Fear recognition: the
significant effect of cocaine dependence at step 1 does not survive when verbal IQ is included in the model in step 2, suggesting that verbal IQ mediates fear
recognition performance in cocaine-dependent individuals. Anger recognition: opiate dependence shows a highly significant effect at stage 1, and this effect
survives the inclusion of verbal intelligence in the model. P is probability (*Po0.05; **Po0.001. The top half of the table shows the results for fear and the
bottom half shows the results for anger.
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Prediction of individual variation in brain-behavior networks by
steroidal hormones
We used multiple stepwise regression analysis to further examine
the extent to which steroidal hormone levels accounted for
participants’ brain-behavior relationships. The model revealed that
testosterone accounted for 12% of the variance in brain scores
associated with angry facial expression recognition (R2 = 0.13,
F1,52 = 8.53, P= 0.008); cortisol had no explanatory value. We
subsequently discovered significant group-by-testosterone inter-
actions on variations in the anger brain score (F2,52 = 4.41,
P= 0.017). A mediation analysis confirmed that the direct effect
of cocaine on testosterone was significant (t=− 2.29, P= 0.026), as
were the direct effects of both testosterone (t= 2.44, P= 0.018)
and cocaine dependence (t=− 2.04, P= 0.048) on the anger brain
score, respectively. However, when testosterone was added to the
model, the direct effect of cocaine dependence was no longer
significant (t=− 1.31, P= 0.196; see Figure 3b), suggesting that
testosterone is mediating the effect of cocaine on the anger brain
score. For fear recognition, neither cortisol nor testosterone levels
accounted for variations in brain score.
Relationships with drug use and physiological indices
Brain scores related to the recognition of angry faces in CDIs were
significantly inversely correlated with duration of crack use
(r=− 0.44, Po0.05), but not with duration of powdered cocaine
or opiate use (both P40.5). Testosterone levels were also inversely
correlated with the duration of crack (r=− 0.51, P= 0.012) and
opiate use (r=− 0.57, P= 0.021), but not with the use of powdered
cocaine (r=− 0.17, P= 0.409). No relationships were identified with
regard to fearful face recognition brain score or cortisol levels.
DISCUSSION
Collectively, our data provide novel insight into the neurobiolo-
gical basis of abnormal threat processing in cocaine dependence.
As hypothesized, and consistent with previous studies,2,3,10,53 we
show that cocaine dependence is associated with impaired
recognition of fearful facial expressions and may also extend to
another threat-related expression—anger. In contrast to previous
research, we reveal the important influence of intelligence on
facial threat recognition and the related variations in anatomical
Figure 2. Clusters of gray matter density that are associated with successful recognition of fearful (a) and angry (b) facial expressions, as
identified by PLS. The numerical values within each cluster are known as salience (comparable with the component load in a principal
component analysis), reflecting the direction of the relationship between gray matter density and behavior. Regions colored in red/yellow
indicate positive salience: increased gray matter density was associated with poor recognition performance (that is, low level of accuracy).
Regions colored in blue reflect negative salience: increased gray matter density was associated with good recognition performance (that is,
high level of accuracy). The numbers below the brain slice denote the z-dimension of each slice in Montreal Neurological Institute (MNI) space.
Each image was thresholded at Z41.96. PLS, partial least squares method; R/L, right/left.
Facing threat in cocaine dependence
KD Ersche et al
6
Translational Psychiatry (2015), 1 – 10
brain structure. Although both groups relied upon the same gray
matter networks, CDIs’ recognition accuracy was less well
predicted by these networks than in controls. This weaker brain-
behavior relationship for fear recognition in CDIs was largely
explained by group differences in intelligence levels. As shown in
Figure 3, low IQ appeared to mediate fear recognition perfor-
mance in CDIs. By contrast, impairments in anger recognition were
mediated by the significantly reduced levels of testosterone
in CDIs.
Facial fear recognition
Out of the six basic emotions, fear is consistently the most
difficult facial expression to recognize,54 and variations in recogni-
tion accuracy have frequently been linked with indices of
intelligence.55–57 Intelligence also seems to be particularly impor-
tant for individuals who have to compensate for dysfunctional brain
networks or damaged brain tissue.58 Further, when psychiatric
patients are compared with IQ-matched control volunteers on tests
of emotion processing, their performance is not measurably
impaired despite persisting perturbations in underlying functional
neural networks.59–61 However, prior research in stimulant drug
users has not investigated the influences of intelligence on fear
recognition performance.2–4 Therefore, we used the National Adult
Reading Test to estimate pre-morbid (not current) intellectual
ability,62 revealing a potential relationship between IQ and fear
recognition in CDIs. Given that stimulant drugs have been shown to
enhance facial emotion recognition,63 it is tempting to speculate
whether fear recognition impairments might impact the risk of
cocaine abuse in individuals with low IQ. The relationship between
intelligence and cocaine use is generally an interesting one: high IQ
has been associated with an increased likelihood of experimenting
with illicit drugs, including cocaine,64 while the risk of developing
dependence in individuals with low IQ is thought to be mediated
by conduct problems during childhood.65 One may speculate
whether the impairments in fear recognition frequently reported in
adolescents with conduct disorder might influence their increased
risk of developing drug dependence.
In light of the strong genetic contribution to both intelligence
and brain morphology,66,67 it is unsurprising that disruptions in
brain networks during emotion recognition have been reported
not only in psychiatric patients, but also in their unaffected first-
degree relatives.68,69 Shared variance between family members in
brain-behavior networks implicated in fear processing is particu-
larly interesting in light of the social context in which fear is
learned,70 as childhood adversity has been shown to either
improve71,72 or impair fear recognition performance.73 Compar-
isons between CDIs and their siblings who share adverse
childhood experiences74 may thus provide insight into compen-
satory mechanisms in fear processing in those siblings who do not
abuse drugs, possibly elucidating sources of resilience.
Finally, attention should be drawn to two observations that
may, at first glance, appear counter-intuitive. First, variations in
trait-anxiety did not affect fear recognition performance in either
group. Prior research suggests that anxious individuals exhibit
hypervigilance to facial signals of covert fear,75,76 but in our study
fearful faces were shown overtly for an extended period of time,
and as such these observations may not be comparable. Second,
although the HPA axis is involved in fear processing, cortisol levels
and fear recognition performance were unrelated in both groups.
Indeed, although acute changes in cortisol have been linked with
processing threat-related stimuli,12,77 basal levels seem to be
unrelated to fearful recognition accuracy, except in individuals
with increased risk for recurrent depression.78
Facial anger recognition
In the current study, emotion recognition impairments in CDIs also
extended to expressions of anger. Converging lines of evidence
from clinical and experimental research indicate that striatal
dopaminergic transmission modulates recognition accuracy of
angry faces.79–81 However, although striatal dopamine function is
diminished in cocaine dependence,82 impairments in anger
recognition have rarely been reported previously in CDIs, except
in those who are co-dependent on a variety of other drugs.53,83
Additional factors are thus likely to mediate the processing of
angry faces. Testosterone levels have been suggested to interact
with striatal dopamine function,84 possibly by modulating neural
reactivity to facial threat,18,19 thereby mediating individuals’
attention and behavioral reactions to angry expressions.85 Indeed,
mediation analysis confirmed that low testosterone levels in CDIs
largely explained their poor recognition of angry faces and the
weak relationship between recognition performance and under-
lying gray matter networks (Figure 3).
It is of note that testosterone levels were significantly reduced
in CDIs with comorbid opiate dependence, possibly due to the
inhibitory effects of opiates on gonadal function.86 Regression
analysis further confirmed the significant effect of comorbid
opiate dependence on anger recognition, suggesting that the low
testosterone levels associated with opiate dependence drive the
impairments in anger recognition. This raises the question as to
why impairments in angry facial expressions have previously not
been reported in opiate-dependent individuals without concomi-
tant crack-cocaine use.87 Possibly, the observed impairments in
angry face perception reflect a combined effect of chronic cocaine
and opiate use on HPA and HPG axes hormones,88 potentially
mediated by altered vasopressin secretion in the hypothalamus89
and thereby influencing social behavior.90,91 Given that neuropep-
tides like oxytocin and vasopressin are being discussed as
potential targets for treatment of drug addiction,92,93 facial affect
recognition tasks could be useful for predicting social implications
associated with this treatment in this highly prevalent but
difficult-to-treat subgroup of crack-cocaine and heroin-dependent
individuals.94
Figure 3. Unstandardized regression coefficients and bias-corrected
95% CI for the indirect effect from a bootstrap-mediation analysis
that found that (a) intelligence mediated the relationship between
cocaine dependence and the brain-behavior network implicated in
fear recognition and (b) testosterone levels mediated the relation-
ship between cocaine dependence and the brain-behavior network
implicated in anger recognition. CI, confidence interval. *denotes
significance at Po0.05. **denotes significance at Po0.001.
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Angry faces are an important social sign of disapproval95 and
may, therefore, be perceived as threatening,96 triggering avoid-
ance responses in anxious individuals or aggression in dominant,
status-seeking individuals.15 Failure to recognize angry faces thus
has dramatic implications for social behavior,97 with a potential
subsequent impact on rehabilitation in CDIs.98 The ratio between
testosterone and cortisol levels seems to determine individuals’
responses to confrontation,99 with an increased testosterone–
cortisol ratio associated with reactive aggression.16,100 As stated
above, in our sample, CDIs’ testosterone levels were significantly
reduced relative to cortisol, suggesting a socially avoidant
response tendency,90,101 an effect previously reported in animal
models of cocaine dependence.102
Methodological considerations and outlook
Although our findings shed new light on disruptions associated
with emotion processing in cocaine dependence, they also raise a
number of questions that warrant further investigation. The group
difference in National Adult Reading Test scores and the
restriction of threat cues to facial expressions should be
considered as a limitation to the study; specifically, the latter
precludes inferences as to whether the impairments seen extend
to other threat signals. The role of gender also warrants
clarification as the current study only included male volunteers.
Further, our study does not address the question about the
sequelae of threat recognition impairments in CDIs during
addiction recovery. Future studies may, therefore, consider
determining whether the observed impairments are reversed
following prolonged drug abstinence.
The multivariate nature of partial least squares provides the
closest structural analog to functional connectivity studies, which
has allowed us to relate the complex neuropathology of addiction
to recognition performance in the same manner as the associated
functional networks of threat processing that have previously
been identified.24 Functional pharmacological and endocrine
challenge studies are now needed to identify the mechanisms
underpinning the described disruptions in threat processing.
Relationships between recognition performance and brain struc-
ture, as we have shown here, may open up new avenues for
elucidating the nature of abnormal functional brain activity
previously reported in individuals at risk for addition69 and with
particularly high recognition accuracy.103
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